Biktarvy release date?

See the DrugPatentWatch profile for Biktarvy

When was Biktarvy first released (FDA approval date)?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) was first approved by the U.S. Food and Drug Administration on July 21, 2018. [1]

When did patients start getting it after approval?

FDA approval in July 2018 is the key “release” milestone; once approved, marketing and pharmacy availability typically followed shortly thereafter as distributors and prescribers adopted the new regimen. [1]

What should I check if I mean “launch date” in another country?

Drug “release date” can differ by market (for example, U.S. FDA approval versus launches in the EU, UK, or other countries). If you tell me the country/region you mean, I can narrow it to the relevant authorization/launch timing. [1]

Related: does Biktarvy have major patent milestones worth tracking?

If you’re researching exclusivity or patents around Biktarvy, DrugPatentWatch.com tracks patent and exclusivity information for branded drugs, including HIV therapies. [2]

Sources:
[1] https://www.drugs.com/history/biktarvy.html
[2] https://www.drugpatentwatch.com/